ETC

Recommend
Index
  • TENELIA® M SR TAB.10/500mg

    TENELIA® M SR TAB.10/500mg

    Ingredient


    Teneligliptin,  Metformin


     

    Content

    Teneligliptin hydrobromide hydrate 15.5mg (10mg as teneligliptin), Metformin hydrochloride 500mg

    Indication

    Tenelia  is for the treatment  of type 2 ciabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase 4 inhibitors. Tenelia, with its potent and sustained action, has been proven highly effective in lowering the postprandial blood glucose levels, as well as fasting blood glucose levels.

  • TENELIA® M SR TAB.10/750mg

    TENELIA® M SR TAB.10/750mg

    Ingredient

    Teneligliptin, Metformin

    Content

    Teneligliptin hydrobromide hydrate 15.5mg (10mg as teneligliptin), Metformin hydrochloride 750mg

    Indication

    Tenelia is for the treatment of type 2 ciabetes mellitus.

    It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase 4 inhibitors. Tenelia, with its potent and sustained action, has been proven highly effective in lowering the postprandial blood glucose levels, as well as fasting blood glucose levels.

  • TENELIA® M SR TAB.20/1000mg

    TENELIA® M SR TAB.20/1000mg

    Ingredient

    Teneligliptin, Metformin

    Content

    Teneligliptin hydrobromide hydrate 31mg (20mg as teneligliptin), Metformin hydrochloride 1000mg

    Indication

    Tenelia  is for the treatment  of type 2 ciabetes mellitus.

    It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase 4 inhibitors. Tenelia, with its potent and sustained action, has been proven highly effective in lowering the postprandial blood glucose levels, as well as fasting blood glucose levels.

  • TENELIA® TAB.20mg

    TENELIA® TAB.20mg

    Ingredient

    teneligliptin

    Content

    teneligliptin hydrobromide hydrate 31mg (20mg as teneligliptin)

    Indication

    Tenelia  is for the treatment  of type 2 ciabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase 4 inhibitors. Tenelia, with its potent and sustained action, has been proven highly effective in lowering the postprandial blood glucose levels, as well as fasting blood glucose levels, through once-a-day administration.

  • Teveten tablet

    Teveten tablet

    Ingredient

    eprosartan

    Content

    600mg

    Indication

    Treatment of essential hypertension.

  • Tracleer® tablet

    Tracleer® tablet

    Ingredient

    Bosentan hydrate

    Content

    62.5mg

    Indication

    Treatment of pulmonary arterial hypertension in patients with WHO Class II-IV symptoms &

    Reduction of the number of new digital ulcers (DUs) in patients with systemic sclerosis (SSc) and ongoing DU disease

  • Trental 400 tablet

    Trental 400 tablet

    Ingredient

    pentoxifylline

    Content

    400mg

    Indication

    Treatment of circulation disorder; cerebral, optical, peripheral arterial.

  • Triapin tablet

    Triapin tablet

    Ingredient

    felodipine/ramipril

    Content

    2.5mg/2.5mg, 5mg/5mg

    Indication

    Treatment of essential hypertension.

  • Tritace Protect tablet

    Tritace Protect tablet

    Ingredient

    ramipril

    Content

    10mg

    Indication

    Treatment of essential hypertension.
    Reduction in risk of myocardial Infarction, stroke, and death from cardiovascular causes.

    Heart failure post myocardial infarction

    Nephrosis

  • Tritace tablet

    Tritace tablet

    Ingredient

    ramipril

    Content

    2.5mg, 5mg

    Indication

    Treatment of essential hypertension.
    Reduction in risk of myocardial Infarction, stroke, and death from cardiovascular causes.

    Heart failure post myocardial infarction

    Nephrosis

TOP